We found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitlePhase 1 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: a North American Brain Tumor Consortium study.AuthorsPrados MD; Yung WK; Jaeckle KA; Robins HI; Mehta MP; Fine HA; Wen PY; Cloughesy TF; Chang SM; Nicholas MK; Schiff D; Greenberg HS; Junck L; Fink KL; Hess KR; Kuhn JPublicationNeuro-oncology, 2004, Vol 6, Issue 1, p44ISSN1522-8517Publication typearticleDOI10.1215/S1152851703000292